Kosár: Jelenleg üres
Keresés
 
Termék adatlap

Omega 3 zsírsavat tartalmazó étrend-kiegészítő lágyzselatin kapszula.


5.490 Ft

Az omega-3 a halolajból származik, az eikozapentaén-sav (EPA) és a dokozahexaén-sav (DHA) kétféle módon, trigliceridek vagy etil-észterek formájában juthat el a fogyasztóhoz. Az egyik legvitatottabb kérdés, ami a halolajat körüllengi az az, hogy melyik formában a legjobb fogyasztani trigliceridként vagy etil-észterként?

Amikor halat eszünk milyen formában vesszük magunkhoz a hosszú láncú omega-3 zsírsavakat? A válasz, hogy triglicerid formájában. Az elfogyasztott zsírok 98%-a triglicerid formájában található meg.

Kiszerelés: 60 db lágyzselatin kapszula

Az omega-3 zsírsav etil-észter formáját tartalmazó táplálékkiegészítők egyre elterjedtebbek az áruk miatt, ugyanis olcsóbban lehet őket előállítani, mint a triglicerideket.  



A különböző omega-3 formák biohozzáférhetőségét Dyerberg (a halolaj atyja) határozta meg. 72 egészséges egyénnek adott 2 héten át újra észterifikált zsírsavat vagy észter mentes zsírsavat vagy halolajat esetleg tőkehalmáj olajat. Az EPS és DHS szintek a trigliceridet fogyasztók csoportjában voltak a legmagasabbak, míg a tőkehalmáj olajat fogyasztókéban a legalacsonyabbak. Egy hasonló tanulmány megállapította, hogy az omega-3 csupán 20%-a szívódik fel etil-észter formájában, hacsak nem magas zsírtartalamú étellel fogyasztjuk.

 

Napi ajánlott mennyiség:2 db lágyzselatin kapszula.

Hatóanyag tartalom a napi adagban: tiszta halolaj 2400mg, ebből: EPA (eikozapentaén-sav)  776 mg,DHA (dokozahexaén-sav) 520 mg, egyéb omega 3 118 mg, E vitamin (összetett tokoferolok) 6mg (50% RDA*). *RDA: felnőttek számára ajánlott napi bevitel.

Miért válasszam a Natures Aid-et?

Minden Natures Aid Omega-3 707 kapszula 707 mg omega-3 zsírsavat tartalmaz triglicerid formájában. Minden kapszula 368 mg EPS-t és 260 mg DHS-t , valamint 59 mg egyéb omega-3 zsírsavat tartalmaz.

Garantáltan mentes nehézfémsóktól és egyéb szennyeződésektől!

 

Figyelmeztetések:

Rövid idejű, átmeneti vércukoszint- és koleszterinszint emelkedés előfordulhat ha nagy mennyiségű halolajat fogyasztunk. E kezdeti szak után a koleszterinszint- és trigliceridszint csökkenése várható. Azok, akik antikoagulánsokat szednek, mint a Warfarin ne lépjék túl a javasolt adagolást. A napi ajánlott mennyiséget ne lépje túl! Hűvös száraz helyen, kisgyermekektől elzárva tartandó! Az étrend-kiegészítő nem helyettesíti a vegyes étrendet és az egészséges életmódot. Ne szedje, ha bármely összetevőjére túlérzékeny!

References:

www.tenyek-tevhitek.hu/omega-3-mentalis-zavarok-lelki-betegsegek.htm

  • Chiu, C-C.; Huang, S-Y.; Shen, W.W.; Su, K.P. Omega-3 polyunsaturated fatty acids for postpartum depression. Am. J. Obstetr. Gyn., 2004, 190(2):582-583.
  • Christensen, O.; Christensen, E.: Fat consumption and schizophrenia Acta Psychiatrica Scandinavica, 1988, 78:587-591.
  • Cott J.; Hibbeln J.R.: Lack of seasonal mood change in Icelanders. Am. J. Psychiatry., 2001, 158(2):328.
  • De Vriese, S.R.; Christophe, A.B.; Maes, M.: In humans, the seasonal variation in poly-unsaturated fatty acids is related to the seasonal variation in violent suicide and serotonergic markers of violent suicide. Prostaglandins. Leukot. Ess. Fat. Acids, 2004, 71(1):13-8.
  • Frangou, S.; Lewis, M.; McCrone, P.: Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br. J. Psychiatry, 2006, 188:46-50.
  • Freeman, MP.: Omega-3 fatty acids in psychiatry: a review. Ann. Clin. Psychiatry, 2000, 12(3):159-65.
  • Gesch, C.B.; Hammond, S.M.; Hampson, S.E.; Eves, A.; Crowder, M.J.: Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners. Randomised, placebo-controlled trial, Br. J. Psychiatry, 2002, 181: 22–28.
  • Gibbons, A.: Human's head start: new views of brain evolution. Science, 2001, 296:835-837.,
  • Glen, AI.; Glen, EM.; Horrobin, DF.; Vaddadi, KS.; Spellman, M.; Morse-Fisher, N.; Ellis, K.; Skinner, FS.: A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases. Schizophr. Res. 1994, 12(1):53-61.
  • Hamazaki, T.; Sawazaki S.; Kobayashi, M.: The effect of docosahexaenoic acid on aggression in young adults. A double-blind study, J. Clin. Invest. , 1996, 97:1129–1134.
  • Hamazaki, T.; Thienprasert, A.; Kheovichai, K.; Samuhaseneetoo, S.; Nagasawa, T.; Watanabe, S.: The effect of docosahexaenoic acid on aggression in elderly Thai subjects-a placebo-controlled double-blind study, Nutr. Neurosci., 2002, 5:37–41
  • Hibbeln, J.R. : Fish consumption and major depression. Lancet. 1998, 351(9110):1213.
  • Hibbeln, J.R.: Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J. Affect. Disord., 2002, 69(1-3):15-29.
  • Hibbeln, J.R.; Salem, N, Jr.: Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy.Am. J. Clin. Nutr., 1995, 62(1):1-9.
  • Hibbels, J.R.: Seafood consumption and homicide mortality. In: Hamazaki, T.; Okuyama, H.(eds.): Fatty acids and lipids – new findings. World. Rev. Nutr. Diet. Basel, Karger, 2001 88:41-46.
  • Hirayama, T.: Life-Style and Mortality: A Large Census-Based Cohort Study in Japan. Basel, Switzerland: Karger; 1990.
  • Llorente, A.M.; Jensen, C.L.; Voigt, R.G.; Fraley, J.K.; Berretta, M.C.; Heird, W.C.: Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am. J. Obstetr. Gyn., 2003, 188:1348–1353.
  • Magnusson, A.; Axelsson, J.; Karlsson, MM.; Oskarsson, H.: Lack of seasonal mood change in the Icelandic population: results of a cross-sectional study. Am. J. Psychiatry., 2000, 157(2):234-8.
  • Nemets, B.; Stahl, Z.; Belmaker, R.H: Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am. J. Psychiatry, 2002, 159:477-479
  • Nemets, H.; Nemets, B.; Apter, A.; Bracha, Z.; Belmaker, RH.: Omega-3 treatment of childhood depression: a controlled, double-blind pilot study.Am. J. Psychiatry., 2006, 163(6):1098-100.
  • Nettleton, J.A.: Omega-3 fatty acids and health. Chapman and Hall New York, 1995.
  • Noaghiul, S.; Hibbeln, JR.: Cross-national comparisons of seafood consumption and rates of bipolar disorders.Am. J. Psychiatry., 2003, 160(12):2222-7.
  • Peet, M.: Nutrition and schizophrenia: beyond omega-3 fatty acids. Prostaglandins, Leukot. Ess. Fat. Acids, 2004, 70:417–422
  • Peet, M.; Horrobin, D.F: A Dose-Ranging Study of the Effects of Ethyl-Eicosapentaenoate in Patients With Ongoing Depression Despite Apparently Adequate Treatment With Standard Drugs. Arch. Gen. Psychiatry, 2002, 59:913-919.
  • Peet, M.; Laugharne, JDE.; Mellor, J.; Ramchand, CN. Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation. Prostaglandins Leukot. Ess. Fat. Acids, 1996, 55:71-5.
  • Peet, M.; Murphy, B.; Shay, J.; Horrobin, D.F.: Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol. Psychiatry., 1998, 43(5):315-9.
  • Stoll, A.L.; Severus, W.E.; Freeman, M.P.; Rueter, S.; Zboyan, H.A.; Diamond, E.; Cress, K.K.; Marangell, L.B.: Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch. Gen. Psychiatry, 1999, 56(5):407-12.
  • Su, KP.; Huang, SY.; Chiu, CC.; Shen, WW.: Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.Eur. Neuropsychopharmacol., 2003, 13(4):267-71
  • Sublette, M.E.; Hibbeln, J.R.; Galfalvy, H.; Oquendo, M.A.; Mann, J.J.: Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk.Am J. Psychiatry. 2006, 163(6):1100-2.
  • Sublette, M.E.; Hibbeln, J.R.; Galfalvy, H.; Oquendo, M.A.; Mann, J.J.:, Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. Am. J. Psychiatry, 2006, 163(6):1100-2.
  • Tanskanen, A.; Hibbeln, JR.; Hintikka, J.; Haatainen, K.; Honkalampi, K.; Viinamaki, H.: Fish consumption, depression, and suicidality in a general population. Arch. Gen. Psychiatry. 2001, 58(5):512-3.
  • Timonen, M.; Horrobin, D.; Jokelainen, J.; Laitinen, J.; Herva, A.; Rasanen, P.: Fish consumption and depression: the Northern Finland 1966 birth cohort study.J. Affect. Disord., 2004, 82(3):447-52.
  • van Praag, H.M.; de Kloet, R; van Os, J: Stress, the brain and depression. Cambridge Univ. Press. 2004.
  • Wilson, C.J.; Finch, C.E. & Cohen, H.J.: Cytokines and cognition-The case for a head-to-toe inflammatory paradigm. J. Am. Geriatr. Soc., 2002, 50(12):2041-2056.
  • Zanarini, MC.; Frankenburg, FR.: Omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am. J. Psychiatry, 2003, 160(1):167-9.
  •    1. ^ Venturi S; Bégin ME (2010). "Thyroid Hormone, Iodine and Human Brain Evolution". In Cunnane S; Stewart K. Environmental Influences on Human Brain Evolution. John Wiley & Sons. pp. 105–124. ISBN 978-0-470-45268-4.
       2. ^ Cocchi, M.; Venturi, S. (2000). "Iodide, antioxidant function and Omega-6 and Omega-3 fatty acids: a new hypothesis of a biochemical cooperation?". Progress in Nutrition 2: 15–19.
       3. ^ Ingenbleek, Y; Jung, L; Férard, G; Bordet, F; Goncalves, AM; Dechoux, L (1997). "Iodised rapeseed oil for eradication of severe endemic goitre". Lancet 350 (9090): 1542–5. doi:10.1016/S0140-6736(97)02427-6. PMID 9388412.
       4. ^ Ingenbleek Y, Jung L, Férard G (2000). "Brassiodol: A new iodised oil for eradication of endemic goitre". Journal of Trace Elements in Medicine and Biology 13 (1): 85–96. doi:10.1002/(SICI)1520-670X(2000)13:1<85::AID-JTRA10>3.0.CO;2-E.
       5. ^ Holman RT (February 1998). "The slow discovery of the importance of omega 3 essential fatty acids in human health". J. Nutr. 128 (2 Suppl): 427S–433S. PMID 9478042.
       6. ^ Dyerberg J, Bang HO, Hjorne N (1975). "Fatty acid composition of the plasma lipids in Greenland Eskimos". Am J Clin Nutr 28 (9): 958–66. PMID 1163480.
       7. ^ a b "FDA announces qualified health claims for omega-3 fatty acids" (Press release). United States Food and Drug Administration. September 8, 2004. http://www.fda.gov/SiteIndex/ucm108351.htm. Retrieved 2006-07-10.
       8. ^ Canadian Food Inspection Agency. Summary Table of Biological Role Claims Table 8-2. http://www.inspection.gc.ca/english/fssa/labeti/guide/ch8e.shtml
       9. ^ a b c d e f Lands, William E.M. (1 May 1992). "Biochemistry and physiology of n–3 fatty acids". FASEB Journal (Federation of American Societies for Experimental Biology) 6 (8): 2530–2536. PMID 1592205. http://www.fasebj.org/content/6/8/2530.full.pdf. Retrieved 2008-03-21.
      10. ^ Bergstrom, Danielson, Klenberg, and Samuelsson (Nov 1964). "The Enzymatic Conversion of Essential fatty Acids into Prostaglandins". The Journal of Biological Chemistry 239 (11): PC4006–PC4008. http://www.jbc.org/content/239/11/PC4006.full.pdf.
      11. ^ Shearer GC, Harris WS, Pedersen TL, Newman JW. (August 2009) Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters. J Lipid Res. Full Free text
      12. ^ Da Young Oh, Saswata Talukdar, Eun Ju Bae, Takeshi Imamura, Hidetaka Morinaga, WuQiang Fan, Pingping Li, Wendell J. Lu, Steven M. Watkins, Jerrold M. Olefsky. (September 2010) GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects. Cell, Volume 142, Issue 5, 687-698, 3 September 2010. [1]
      13. ^ Gerster H (1998). "Can adults adequately convert alpha-linolenic acid (18:3n-3) to eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)?". Int. J. Vitam. Nutr. Res. 68 (3): 159–173. PMID 9637947.
      14. ^ Brenna JT (March 2002). "Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man.". Curr. Opin. Clin. Nutr. Metab. Care 5 (2): 127–132. doi:10.1097/00075197-200203000-00002. PMID 11844977.
      15. ^ Burdge GC, Calder PC (September 2005). "Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults.". Reprod. Nutr. Dev. 45 (5): 581–597. doi:10.1051/rnd:2005047. PMID 16188209.
      16. ^ "Conversion Efficiency of ALA to DHA in Humans". http://dhaomega3.org/index.php?category=overview&title=Conversion-of-ALA-to-DHA. Retrieved 21 October 2007.
      17. ^ Goyens, Petra LL et al. (1 July 2006). "Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio". American Journal of Clinical Nutrition 84 (1): 44–53. PMID 16825680. http://www.ajcn.org/cgi/content/abstract/84/1/44. Retrieved 21 October 2007.
      18. ^ Okuyama H (2001). "High n−6 to n−3 ratio of dietary fatty acids rather than serum cholesterol as a major risk factor for coronary heart disease". Eur J Lipid Sci Technol 103 (6): 418–422. doi:10.1002/1438-9312(200106)103:6<418::AID-EJLT418>3.0.CO;2-#.
      19. ^ Griffin BA (2008). "How relevant is the ratio of dietary n−6 to n−3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study". Curr. Opin. Lipidol. 19 (1): 57–62. doi:10.1097/MOL.0b013e3282f2e2a8. PMID 18196988.
      20. ^ Mozaffarian D, Ascherio A, Hu FB, Stampfer MJ, Willett WC, Siscovick DS, Rimm EB., D; Ascherio, A; Hu, FB; Stampfer, MJ; Willett, WC; Siscovick, DS; Rimm, EB (2005). "Interplay Between Different Polyunsaturated Fatty Acids and Risk of Coronary Heart Disease in Men". Circulation 111 (2): 157–64. doi:10.1161/01.CIR.0000152099.87287.83. PMC 1201401. PMID 15630029. http://circ.ahajournals.org/cgi/content/full/111/2/157.
      21. ^ Willett WC, WC (2007). "The role of dietary n-6 fatty acids in the prevention of cardiovascular disease". J Cardiovasc Med 8: Suppl 1:S42–5. doi:10.2459/01.JCM.0000289275.72556.13. PMID 17876199.
      22. ^ Tribole, E.F.; Thompson, RL; Harrison, RA; Summerbell, CD; Ness, AR; Moore, HJ; Worthington, HV; Durrington, PN et al. (2006). "Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review". BMJ 332 (7544): 752–760. doi:10.1136/bmj.38755.366331.2F. PMC 1420708. PMID 16565093. http://www.bmj.com/cgi/eletters/332/7544/752#130637. Retrieved 2008-03-23.
      23. ^ a b c S.K. Duckett et al, Journal of Animal Science, (published online) June 2009, “Effects of winter stocker growth rate and finishing system on: III. Tissue proximate, fatty acid, vitamin and cholesterol content.”
      24. ^ Tribole, 2007
      25. ^ Lands, 2005
      26. ^ Simopoulos, AP (September 2003). "Importance of the ratio of omega-6/omega-3 essential fatty acids: evolutionary aspects". World Review of Nutrition and Dietetics. World Review of Nutrition and Dietetics 92: 1–174. doi:10.1159/000073788. ISBN 3-8055-7640-4. PMID 14579680.
      27. ^ Simopoulos AP, Leaf A, Salem Jr N (2000). "Workshop Statement on the essentiality of and recommended dietary intakes for n−6 and n−3 fatty acids". Prostaglandins Leukot Essent Fatty Acids 63 (3): 119–121. doi:10.1054/plef.2000.0176. PMID 10991764.
      28. ^ Hibbeln et al., 2006
      29. ^ Erasmus, Udo, Fats and Oils. 1986. Alive books, Vancouver, ISBN 0-920470-16-5 p. 263 (round-number ratio within ranges given.)
      30. ^ "Essential Fats in Food Oils, NIH page". http://efaeducation.nih.gov/sig/esstable.html.
      31. ^ "Ask the Expert: Omega-3 Fatty Acids". Harvard University. 21 April 2009. http://www.hsph.harvard.edu/nutritionsource/questions/omega-3/index.html. Retrieved 6 April 2011. ""Omega-6 fatty acids lower LDL cholesterol (the "bad" cholesterol) and reduce inflammation, and they are protective against heart disease. So both omega-6 and omega-3 fatty acids are healthy. While there is a theory that omega-3 fatty acids are better for our health than omega-6 fatty acids, this is not supported by the latest evidence. Thus, the omega-3 to omega-6 ratio is basically the "good divided by the good," so it is of no value in evaluating diet quality or predicting disease.""
      32. ^ von Schacky C. (March 2003). "The role of omega-3 fatty acids in cardiovascular disease". Curr. Atheroscler. Rep. 5 (2): 139–45. doi:10.1007/s11883-003-0086-y. PMID 12573200.
      33. ^ name="EPA" [2],
      34. ^ Morris, Martha C.; Sacks, Frank; Rosner, Bernard (1993). "Does fish oil lower blood pressure? A meta-analysis of controlled trials". Circulation 88 (2): 523–533. PMID 8339414. http://circ.ahajournals.org/cgi/reprint/88/2/523/.
      35. ^ Mori, Trevor A.; Bao, Danny Q.; Burke, Valerie; Puddey, Ian B.; Beilin, Lawrence J. (1993). "Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans". Hypertension 34 (2): 253–260. PMID 10454450. http://hyper.ahajournals.org/cgi/reprint/34/2/253/.
      36. ^ Harris, William S. (1997). "n−3 fatty acids and serum lipoproteins: human studies". Am J Clin Nutr 65 (5 Sup.): 1645S–1654S. PMID 9129504. http://www.ajcn.org/cgi/reprint/65/5/1645S/.
      37. ^ Sanders, T.A.B.; Oakley, F.R.; Miller, G.J.; Mitropoulos, K.A.; Crook, D.; Oliver, M.F. (1997). "Influence of n−6 versus n−3 polyunsaturated fatty acids in diets low in saturated fatty acids on plasma lipoproteins and hemostatic factors". Arteriosclerosis, Thrombosis, and Vascular Biology 17 (12): 3449–3460. doi:10.1161/01.ATV.17.12.3449. PMID 9437192. http://atvb.ahajournals.org/cgi/content/full/17/12/3449.
      38. ^ Roche, H.M.; Gibney, M.J. (1996). "Postprandial triacylglycerolaemia: the effect of low-fat dietary treatment with and without fish oil supplementation". Eur J Clin Nutr. 50 (9): 617–624. PMID 8880041. http://cat.inist.fr/?aModele=afficheN&cpsidt=3232572.
      39. ^ Davidson MH, Stein EA, Bays HE, Maki KC, Doyle RT, Shalwitz RA, Ballantyne CM, Ginsberg HN (2007). "Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study". Clin Ther. 29 (7): 1354–1367. doi:10.1016/j.clinthera.2007.07.018. PMID 17825687.
      40. ^ Bucher HC, Hengstler P, Schindler C, Meier G. (2002). "n−3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials". Am J Med 112 (4): 298–304. doi:10.1016/S0002-9343(01)01114-7. PMID 11893369.
      41. ^ Burr, Michael L.; Sweetham, P.M.; Fehily, Ann M. (August 1994). "Diet and reinfarction". European Heart Journal 15 (8): 1152–1153. PMID 7988613. http://eurheartj.oxfordjournals.org/cgi/reprint/15/8/1152.
      42. ^ Willett, Walter C.; Stampfer, M.J.; Colditz, G.A.; Speizer, F.E.; Rosner, B.A.; Hennekens, C.H. (1993). "Intake of trans fatty acids and risk of coronary heart disease among women". The Lancet 341 (8845): 581–585. doi:10.1016/0140-6736(93)90350-P. PMID 8094827.
      43. ^ Stone, Neil J. (1996). "Fish consumption, fish oil, lipids, and coronary heart disease". Circulation 94 (9): 2337–2340. PMID 8901708. http://circ.ahajournals.org/cgi/content/full/94/9/2337.
      44. ^ Wang, C.; Harris, W. S.; Chung, M.; Lichtenstein, A. H.; Balk, E. M.; Kupelnick, B.; Jordan, H. S.; Lau, J. (2006). "N-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review". The American journal of clinical nutrition 84 (1): 5–17. PMID 16825676.  edit
      45. ^ Fortin PR, Lew RA, Liang MH, Wright EA, Beckett LA, Chalmers TC, Sperling RI. (1995). "Validation of a meta-analysis: The effects of fish oil in rheumatoid arthritis". J Clin Epidemiol 48 (11): 1379–1390. doi:10.1016/0895-4356(95)00028-3. PMID 7490601.
      46. ^ Kremer, Joel M.; Bigauoette, J.; Michalek, A.V.; Timchalk, M.A.; Lininger, L.; Rynes, R.I.; Huyck, C.; Zieminski, J.; Bartholomew, L.E. (1985). "Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis". The Lancet (Elsevier) 1 (8422): 184–187. doi:10.1016/S0140-6736(85)92024-0. PMID 2857265.
      47. ^ Christensen, Jeppe H.; Gustenhoff, Peter; Ejlersen, Ejler; Jessen, Torben; Korup, Eva; Rasmussen, Klaus; Dyerberg, Jørn; Schmidt, Erik B. (January 1995). "n−3 fatty acids and ventricular extrasystoles in patients with ventricular tachyarrhythmias". Nutrition Research 15 (1): 1–8. doi:10.1016/0271-5317(95)91647-U.
      48. ^ Christensen, Jeppe H.; Gustenhoff, Peter; Korup, Eva; Aarøe, Jens; Toft, Egon; Møller, Torn; Rasmussen, Klaus; Dyerberg, Jørn; Schmidt, Erik B. (1996-03-16). "Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial". BMJ 312 (7032): 677–678. PMC 2350515. PMID 8597736. http://www.bmj.com/cgi/content/full/312/7032/677.
      49. ^ Pignier, C.; Revenaz, C.; Rauly-Lestienne, I.; Cussac, D.; Delhon, A.; Gardette, J.; Le Grand, B. (2007). "Direct protective effects of poly-unsaturated fatty acids, DHA and EPA, against activation of cardiac late sodium current". Basic Research in Cardiology (Steinkopff Verlag) 102 (6): 553–564. doi:10.1007/s00395-007-0676-x. PMID 17891522. http://www.springerlink.com/content/u454873774830225/.
      50. ^ a b Su, Kuan-Pin; Huang, Shih-Yi; Chiub, Chih-Chiang; Shenc, Winston W. (2003). "Omega-3 fatty acids in major depressive disorder: A preliminary double-blind, placebo-controlled trial". Eur Neuropsychopharmacol 13 (4): 267–271. doi:10.1016/S0924-977X(03)00032-4. PMID 12888186.
      51. ^ Naliwaiko, K.; Araújo, R.L.; da Fonseca, R.V.; Castilho, J.C.; Andreatini, R.; Bellissimo, M.I.; Oliveira, B.H.; Martins, E.F.; Curi, R.; Fernandes, L.C.; Ferraz, A.C. (April 2004). "Effects of fish oil on the central nervous system: a new potential antidepressant?". Nutritional Neuroscience (Maney) 7 (2): 91–99. doi:10.1080/10284150410001704525. PMID 15279495.
      52. ^ Nemets, Boris; Stahl, Ziva; Belmaker, R.H. (2002). "Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder". Am J Psychiatry 159 (3): 477–479. doi:10.1176/appi.ajp.159.3.477. PMID 11870016.
      53. ^ Green, Pnina; Hermesh, Haggai; Monselisec, Assaf; Maromb, Sofi; Presburgerb, Gadi; Weizman, Abraham (2006). "Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder". Eur Neuropsychopharmacol 16 (2): 107–113. doi:10.1016/j.euroneuro.2005.07.005. PMID 16243493.
      54. ^ Yehuda S., Rabinovitz S., Mostofsky D.I. (2005). "Mixture of essential fatty acids lowers test anxiety". Nutritional Neuroscience 8 (4): 265–267. doi:10.1080/10284150500445795. PMID 16491653.
      55. ^ Caryn Rabin, Roni (October 26, 2009). "Regimens: Omega-3 Fats Fail to Lift Depression in Heart Patients". The New York Times. http://www.nytimes.com/2009/10/27/health/research/27regimens.html.
      56. ^ Carney, Robert; Freedland, Kenneth; Rubin, Eugene; Rich, Michael; Steinmeyer, Brian; Harris, William (2009). "Omega-3 Augmentation of Sertraline in Treatment of Depression in Patients with Coronary Heart Disease". JAMA 302 (15): 1651–1657. doi:10.1001/jama.2009.1487. PMID 19843899.  http://jama/ama-assn.org/cgi/content/full/302/15/1651
      57. ^ Keli, S.O.; Feskens, E.J.; Kromhout, D. (1994). "Fish consumption and risk of stroke: The Zutphen Study". Stroke 25 (2): 328–332. doi:10.1161/01.STR.25.2.328. PMID 8303739.
      58. ^ Gillum, R.F.; Mussolino, M.E.; Madans, J.H. (1996). "The relationship between fish consumption and stroke incidence: The NHANES I Epidemiologic Follow-up Study (National Health and Nutrition Examination Survey)". Arch Intern Med 156 (5): 537–542. doi:10.1001/archinte.156.5.537. PMID 8604960.
      59. ^ a b Iso, H.; Rexrode, K.M.; Stampfer, M.J.; Manson, J.E.; Colditz, G.A.; Speizer, F.E.; Hennekens, C.H.; Willett, W.C. (2001). "Intake of fish and omega-3 fatty acids and risk of stroke in women". JAMA 285 (3): 304–312. doi:10.1001/jama.285.3.304. PMID 11176840.
      60. ^ The U.S. Food and Drug Administration classification - GRAS (Generally Recognized as Safe)
      61. ^ Augustsson, Katarina et al. (2003). "A prospective study of intake of fish and marine fatty acids and prostate cancer". Cancer Epidemiology, Biomarkers & Prevention 12 (1): 64–67. PMID 12540506.
      62. ^ De Deckere, E.A. (1999). "Possible beneficial effect of fish and fish n−3 polyunsaturated fatty acids in breast and colorectal cancer". Eur J Cancer Prev 8 (3): 213–221. doi:10.1097/00008469-199906000-00009. PMID 10443950.
      63. ^ Caygill, C.P.; Hill, M.J. (1995). "Fish, n−3 fatty acids and human colorectal and breast cancer mortality". Eur J Cancer Prev 4 (4): 329–332. doi:10.1097/00008469-199508000-00008. PMID 7549825.
      64. ^ Yong Q. Chen et al. (2007). "Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids". J Clin Invest 117 (7): 1866–75. doi:10.1172/JCI31494. PMC 1890998. PMID 17607361. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1890998.
      65. ^ Pala V et al. (2001). "Erythrocyte Membrane Fatty Acids and Subsequent Breast Cancer: a Prospective Italian Study". JNCL 93 (14): 1088–95. doi:10.1093/jnci/93.14.1088. PMID 11459870. http://jnci.oxfordjournals.org/cgi/content/full/93/14/1088. Retrieved 2008-11-30.
      66. ^ Brasky T et al. (2011). "Serum Phospholipid Fatty Acids and Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial". Am. J. Epidemiol. 173 (12): 1429–39. doi:10.1093/aje/kwr027. PMC 3145396. PMID 21518693. http://aje.oxfordjournals.org/content/early/2011/04/19/aje.kwr027.full.pdf+html. Retrieved 2011-04-24.
      67. ^ Fred Hutchinson Cancer Research Center (2011-04-25). "High percentage of omega-3s in the blood may boost risk of aggressive prostate cancer". eurekalert.org. http://www.eurekalert.org/pub_releases/2011-04/fhcr-hpo042511.php. Retrieved 2011-08-10.
      68. ^ MacLean, Catherine H. et al. (2006). "Effects of n−3 Fatty Acids on Cancer Risk". JAMA 295 (4): 403–415. doi:10.1001/jama.295.4.403. PMID 16434631. http://jama.ama-assn.org/cgi/content/short/295/4/403. Retrieved 2006-07-07.
      69. ^ Lee Hooper et al. (2006). "Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review". BMJ 332 (7544): 752–760. doi:10.1136/bmj.38755.366331.2F. PMC 1420708. PMID 16565093. http://bmj.bmjjournals.com/cgi/reprint_abr/332/7544/752/. Retrieved 2006-07-07.
      70. ^ Colomer R, Moreno-Nogueira JM, García-Luna PP et al. (May 2007). "N-3 fatty acids, cancer and cachexia: a systematic review of the literature". Br. J. Nutr. 97 (5): 823–31. doi:10.1017/S000711450765795X. PMID 17408522.
      71. ^ Ryan AM, Reynolds JV, Healy L et al. (2009). "Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial". Ann. Surg. 249 (3): 355–63. doi:10.1097/SLA.0b013e31819a4789. PMID 19247018.
      72. ^ (1999). "Dietary supplementation with n−3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial". Lancet 354 (9177): 447–455. doi:10.1016/S0140-6736(99)07072-5. PMID 10465168.
      73. ^ Marchioli R.; Barzi, F; Bomba, E; Chieffo, C; Di Gregorio, D; Di Mascio, R; Franzosi, MG; Geraci, E et al. (2002). "Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the GISSI-Prevenzione". Circulation 105 (16): 1897–1903. doi:10.1161/01.CIR.0000014682.14181.F2. PMID 11997274.
      74. ^ a b Trivedi, Bijal (2006-09-23). "The good, the fad, and the unhealthy". New Scientist: pp. 42–49. http://www.newscientist.com/channel/health/mg19125701.300-the-good-the-fad-and-the-unhealthy.html.
      75. ^ Wang, C; Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, Jordan HS, Lau J (July 2006). "n−3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review". Am J Clin Nutr 84 (1): 5–17. PMID 16825676.
      76. ^ Mozaffarian, Dariush; Rimm, Eric B. (October 2006). "Fish intake, contaminants, and human health: evaluating the risks and the benefits". JAMA 296 (15): 1885–1899. doi:10.1001/jama.296.15.1885. PMID 17047219.
      77. ^ Mita, T; Watada H, Ogihara T, Nomiyama T, Ogawa O, Kinoshita J, Shimizu T, Hirose T, Tanaka Y, Kawamori R (2007). "Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes". Atherosclerosis 191 (1): 162–167. doi:10.1016/j.atherosclerosis.2006.03.005. PMID 16616147.
      78. ^ McKenney, James M.; Sica, Domenic (2007). "Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia". Am J Health-Sys Pharm 64 (6): 595–605. doi:10.2146/ajhp060164. PMID 17353568.
      79. ^ Yokoyama, M; Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K (March 2007). "Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis". Lancet 369 (9567): 1090–1098. doi:10.1016/S0140-6736(07)60527-3. PMID 17398308.
      80. ^ "Nutrition Facts and Analysis for Nuts, Walnuts, English". NutritionData. http://www.nutritiondata.com/facts-C00001-01c20oc.html.
      81. ^ Zambón, D.; Sabaté, J.; Muñoz, S.; Campero, B.; Casals, E.; Merlos, M.; Laguna, J.C.; Ros, E. (2000). "Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women: A randomized crossover trial". Annals of Internal Medicine 132 (7): 538–546. PMID 10744590.
      82. ^ Garrido-Sánchez, L.; García-Fuentes, E.; Rojo-Martínez, G.; Cardona, F.; Soriguer, F.; Tinahones, F.J. (February 2008). "Inverse relation between levels of anti-oxidized-LDL antibodies and eicosapentanoic acid (EPA)". Br J Nut 22 (3): 1–5. doi:10.1017/S0007114508921723. PMID 18252023.
      83. ^ Christiansen J, Gustenhoff P, Korup E, Aaroe J, Toft E, Moller T, & Schmidt, EB (1996). "Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial". British Medical Journal 312 (7032): 677–8. PMC 2350515. PMID 8597736. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2350515.
      84. ^ Murnaghan MF (1981). "Effects of fatty acids on the ventricular arrhythmia threshold in the isolated heart of the rabbit". British Journal of Pharmacology: 909–915.
      85. ^ Appel LF, Miller ER, Sidler AJ, Whelton PK (1993). "Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials". Archives of Internal Medicine 153 (12): 1429–1438. doi:10.1001/archinte.153.12.1429. PMID 8141868.
      86. ^ Damsgaard, Camilla T.; Lauritzen, Lotte; Kjær, Tanja M.R.; Holm, Puk M.I.; Fruekilde, Maj-Britt; Michaelsen, Kim F.; Frøkiær, Hanne (2007). "Fish oil supplementation modulates immune function in healthy infants". J Nutr 137 (4): 1031–1036. PMID 17374672. http://jn.nutrition.org/cgi/reprint/137/4/1031.
      87. ^ Amminger GP, Schäfer M, Papageorgiou K, et al. "Long-Chain omega-3 Fatty Acids for Indicated Prevention of Psychotic Disorders: A Randomized, Placebo-Controlled Trial." Arch Gen Psychiatry. 2010;67(2):146-154. Full Free Text
      88. ^ Taepavarapruk P, Song C. (Dec 2009) "Reductions of acetylcholine release and nerve growth factor expression are correlated with memory impairment induced by interleukin-1beta administrations: effects of omega-3 fatty acid EPA treatment." J Neurochem. [3]
      89. ^ Mischoulon D, Papakostas GI, Dording CM, et al. (Dec 2009) "A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder." Journal of Clinical Psychiatry. [4]
      90. ^ van de Rest, O.; Geleijnse, J. M.; Kok, F.J.; van Staveren, W.A.; Dullemeijer, C.; OldeRikkert, M.G.M.; Beekman, A. T.F.; de Groot, C. P.G.M. (August 2008). "Effect of fish oil on cognitive performance in older subjects". Neurology 71 (6): 430–438. doi:10.1212/01.wnl.0000324268.45138.86. PMID 18678826.
      91. ^ Wall R, Ross RP, Fitzgerald GF, Stanton C (2010). "Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids". Nutr Rev 68 (5): 280–9. doi:10.1111/j.1753-4887.2010.00287.x. PMID 20500789.
      92. ^ Ruggiero C, Lattanzio F, Lauretani F, Gasperini B, Andres-Lacueva C, Cherubini A (2009). "Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids". Curr Pharm Des 15 (36): 4135–48. PMID 20041815.
      93. ^ Lewis, Christine J.. "Letter Regarding Dietary Supplement Health Claim for Omega-3 Fatty Acids and Coronary Heart Disease". http://www.fda.gov/ohrms/dockets/dockets/95s0316/95s-0316-Rpt0272-38-Appendix-D-Reference-F-FDA-vol205.pdf.  and "Letter Regarding Dietary Supplement Health Claim for Omega-3 Fatty Acids and Coronary Heart Disease". U.S. Food and Drug Administration via Internet Archive. October 31, 2000. Archived from the original on 2006-12-17. http://web.archive.org/web/20061217002249/http://vm.cfsan.fda.gov/~dms/ds-ltr11.html. Retrieved 2009-10-30.
      94. ^ a b Ornish, Dean (2006-05-02). "The Dark Side of Good Fats". Newsweek: p. 2. Archived from the original on 2008-05-22. http://web.archive.org/web/20080522084931/http://www.newsweek.com/id/137192. Retrieved 2008-06-14.
      95. ^ Gissi-Hf Investigators; Tavazzi, L; Maggioni, AP; Marchioli, R; Barlera, S; Franzosi, MG; Latini, R; Lucci, D et al. (August 2008). "Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial". Lancet 372 (9645): 1223–30. doi:10.1016/S0140-6736(08)61239-8. PMID 18757090. http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(08)61239-8.
      96. ^ a b Levy, Susan E.; Hyman, Susan L. (2005). "Novel treatments for autistic spectrum disorders". Ment Retard Dev Disabil Res Rev 11 (2): 131–142. doi:10.1002/mrdd.20062. PMID 15977319.
      97. ^ a b c Richardson, Alexandra J. (2006). "Omega-3 fatty acids in ADHD and related neurodevelopmental disorders". Int Rev Psychiatry 18 (2): 155–172. doi:10.1080/09540260600583031. PMID 16777670.
      98. ^ Green, VA; Pituch KA, Itchon J, Choi A, O'Reilly M, Sigafoos J (2006). "Internet survey of treatments used by parents of children with autism". Res Dev Disabil 27 (1): 70–84. doi:10.1016/j.ridd.2004.12.002. PMID 15919178.
      99. ^ Sinn, Natalie; Bryan, Janet (April 2007). "Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD". J Dev Behav Pediatrics 28 (2): 82–91. doi:10.1097/01.DBP.0000267558.88457.a5. PMID 17435458.
     100. ^ Richardson, Alexandra J.; Montgomery, Paul (2005). "The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder". Pediatrics 115 (5): 1360–1366. doi:10.1542/peds.2004-2164. PMID 15867048.
     101. ^ Johnson M, Ostlund S, Fransson G, Kadesjö B, Gillberg C. (30 April 2008). "Omega-3/Omega-6 Fatty Acids for Attention Deficit Hyperactivity Disorder: A Randomized Placebo-Controlled Trial in Children and Adolescents". J Atten Disord 12 (5): 394–401. doi:10.1177/1087054708316261. PMID 18448859.
     102. ^ Bent, Stephen; Bertoglio, Kiah; Hendren, Robert L. (March 2009). "Omega-3 Fatty Acids for Autistic Spectrum Disorder: A Systematic Review". J Autism Dev Disord 39 (8): 1145–54. doi:10.1007/s10803-009-0724-5. PMC 2710498. PMID 19333748. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2710498.
     103. ^ Amminger, G. Paul et al. (2007). "Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study". Biol Psychiatry 61 (4): 551–553. doi:10.1016/j.biopsych.2006.05.007. PMID 16920077.
     104. ^ Gilbert, Donald L. (2008). "Regarding 'omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study'". Biol Psychiatry 63 (2): e13. doi:10.1016/j.biopsych.2007.03.028. PMID 17555722.  Author reply: Amminger, G. Paul; Harrigan, Susan M. (February 2008). "Reply". Biol Psychiatry 63 (2): e15. doi:10.1016/j.biopsych.2007.04.002.
     105. ^ Olsen, Sjúrður Fróði; Secher, Niels Jørgen (2002-02-23). "Low consumption of seafood in early pregnancy as a risk factor for preterm delivery: prospective cohort study". BMJ (Clinical Research Ed.) 324 (7335): 447. doi:10.1136/bmj.324.7335.447. PMC 65663. PMID 11859044. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=65663.
     106. ^ Jensen, Craig L (2006). "Effects of n-3 fatty acids during pregnancy and lactation". Am J Clin Nutr 83 (6): 1452–1457. ISSN 0002-9165. http://www.ajcn.org/cgi/reprint/83/6/S1452.pdf.
     107. ^ Odent, Michel; Colson, Suzanne; De Reu, Paul (2002-05-25). "Consumption of seafood and preterm delivery : Encouraging pregnant women to eat fish did not show effect". BMJ (Clinical Research Ed.) 324 (7348): 1279. PMC 1123229. PMID 12028992. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1123229.
     108. ^ Puri, Basant K. (2006). "High-resolution magnetic resonance imaging sinc-interpolation-based subvoxel registration and semi-automated quantitative lateral ventricular morphology employing threshold computation and binary image creation in the study of fatty acid interventions in schizophrenia, depression, chronic fatigue syndrome, and Huntington's disease". Int Rev Psychiatry 18 (2): 149–154. doi:10.1080/09540260600583015. PMID 16777669.
     109. ^ http://www.scientificamerican.com/article.cfm?id=omega-3-deficiency-depression
     110. ^ Calabrese, J.R.; Rapport, D.J.; Shelton, M.D. (1999). "Fish oils and bipolar disorder: A promising but untested treatment". Arch Gen Psychiatry 56 (5): 413–414; discussion 415–416. doi:10.1001/archpsyc.56.5.413. PMID 10232295.
     111. ^ Stoll, A.L. et al. (1999). "Omega 3 fatty acids in bipolar disorder: A preliminary double-blind, placebo-controlled trial". Arch Gen Psychiatry 56 (5): 407–412. doi:10.1001/archpsyc.56.5.407. PMID 10232294.
     112. ^ Nemets, H.; Nemets, B.; Apter, A.; Bracha, Z.; Belmaker, R.H. (2006). "Omega-3 treatment of childhood depression: A controlled, double-blind pilot study". Am J Psychiatry 163 (6): 1098–1100. doi:10.1176/appi.ajp.163.6.1098. PMID 16741212.
     113. ^ Huan, M. et al. (2004). "Suicide attempt and n−3 fatty acid levels in red blood cells: a case control study in China". Biol Psychiatry 56 (7): 490–496. doi:10.1016/j.biopsych.2004.06.028. PMID 15450784. http://www.journals.elsevierhealth.com/periodicals/bps/article/PIIS0006322304007061/abstract.
     114. ^ http://article.psychiatrist.com/dao_1-login.asp?ID=10007556&RSID=69755683854317
     115. ^ Freeman MP, Hibbeln JR, Wisner KL, et al. (2006) Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry. 2006;67(12):1954-67. Free Full Text
     116. ^ Lin, Pao-Yen; Kuan-Pin Su (July 2007). "A Meta-Analytic Review of Double-Blind, Placebo-Controlled Trials of Antidepressant Efficacy of Omega-3 Fatty Acids". J Clin Psychiatry 68 (7): 1056–1061. doi:10.4088/JCP.v68n0712. PMID 17685742. http://www.psychiatrist.com/privatepdf/2007/v68n07/.
     117. ^ Mischoulon D, Papakostas GI, Dording CM, et al. "A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder." J Clin Psychiatry. 25 August 2009. Abstract
     118. ^ Dietary intake of n-3 and n-6 fatty acids and the risk of clinical depression in women: a 10-y prospective follow-up study. Am J Clin Nutr. 2011 Jun;93(6):1337-43.
     119. ^ a b Food and Nutrition Board, Institute of Medicine of the National Academies (2005), pp.423
     120. ^ a b Food and Nutrition Board, Institute of Medicine of the National Academies (2005), pp.770
     121. ^ "Product Review: Omega-3 Fatty Acids (EPA and DHA) from Fish/Marine Oils". ConsumerLab.com. 2005-03-15. http://www.consumerlab.com/results/omega3.asp. Retrieved 2007-08-14.
     122. ^ Kris-Etherton, PM, Harris, WS, Appel LJ (2002). "Fish consumption, fish oil, omega-3 acids and cardiovascular disease". Circulation 106 (21): 2747–2757. doi:10.1161/01.CIR.0000038493.65177.94. PMID 12438303.
     123. ^ Falk-Petersen, S., S. et al. (1998). "Lipids and fatty acids in ice algae and phytoplankton from the Marginal Ice Zone in the Barents Sea". Polar Biology 20 (1): 41–47. doi:10.1007/s003000050274. ISSN 0722-4060. http://cat.inist.fr/?aModele=afficheN&cpsidt=2356641.
     124. ^ "Fish, Levels of Mercury and Omega-3 Fatty Acids". American Heart Association. http://www.americanheart.org/presenter.jhtml?identifier=3013797. Retrieved October 6, 2010.
     125. ^ Kris-Etherton, Penny M.; William S. Harris, Lawrence J. Appel (2002). "Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease". Circulation 106 (21): 2747–2757. doi:10.1161/01.CIR.0000038493.65177.94. PMID 12438303. http://circ.ahajournals.org/cgi/content/full/106/21/2747.
     126. ^ a b c d e f g h i j k l m n o p q r "Omega-3 Centre". Omega-3 sources. Omega-3 Centre. Archived from the original on 2008-07-18. http://web.archive.org/web/20080718174524/http://www.omega-3centre.com/sources_long_chain.html. Retrieved 2008-07-27.
     127. ^ "Pollutants found in fish oil capsules". BBC News. 2002-04-06. http://news.bbc.co.uk/1/hi/health/1911312.stm. Retrieved 2010-01-06.
     128. ^ Lawson, L.D.; Hughes, B.G. (1988). "Absorption of eicosapentaenoic acid and docosahexaenoic acid from fish oil triacylglycerols or fish oil ethyl esters co-ingested with a high-fat meal". Biochem. Biophys. Res. Commun. 156 (2): 960–963. doi:10.1016/S0006-291X(88)80937-9. PMID 2847723.
     129. ^ Beckermann, B.; Beneke, M.; Seitz, I. (1990). "Comparative bioavailability of eicosapentaenoic acid and docasahexaenoic acid from triglycerides, free fatty acids and ethyl esters in volunteers" (in German). Arzneimittel-Forschung 40 (6): 700–704. PMID 2144420.
     130. ^ Ulven SM; Kirkhus, B; Lamglait, A; Basu, S; Elind, E; Haider, T; Berge, K; Vik, H et al. (January 2011). "Metabolic Effects of Krill Oil are Essentially Similar to Those of Fish Oil but at Lower Dose of EPA and DHA, in Healthy Volunteers". Lipids 46 (1): 37–46. doi:10.1007/s11745-010-3490-4. PMC 3024511. PMID 21042875. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3024511.
     131. ^ Halpern, G.M., The Inflammation Revolution. Square City Publishers, New York 2005. ISBN 0-7570-0283-8
     132. ^ Lyprinol ® - Arthritis, Knee Pain, Anti-Inflammatory, Aching Joint Relief, Cardiovascular Health, Joint Health, Respiratory Health, Stiffness. "Lyprinol in Brief". Lyprinol.com. http://www.lyprinol.com/about1.htm. Retrieved 2011-01-03.
     133. ^ "Seed Oil Fatty Acids - SOFA Database Retrieval". http://sofa.bfel.de.
     134. ^ DeFilippis, Andrew P.; Laurence S. Sperling. "Understanding omega-3's" (PDF). Archived from the original on 22 October 2007. http://web.archive.org/web/20071022174611/http://www.biovita.fi/suomi/pdf/understanding_omega3.pdf. Retrieved 21 October 2007.
     135. ^ Wilkinson, Jennifer. "Nut Grower's Guide: The Complete Handbook for Producers and Hobbyists" (PDF). http://www.publish.csiro.au/samples/Nut%20Growers%20GuideSample.pdf. Retrieved 21 October 2007.
     136. ^ Bartram (1998), pp.271
     137. ^ "Egg Producers Deceive Consumers, Violate Law with Bogus Omega-3 Claims ~ Newsroom ~ News from CSPI ~ Center for Science in the Public Interest". Cspinet.org. 2007-06-21. http://www.cspinet.org/new/200706211.html. Retrieved 2011-01-03.
     138. ^ David Beaulieu. "Edible Landscaping With Purslane". About.com. http://landscaping.about.com/cs/weedsdiseases/a/purslane.htm.
     139. ^ "How Omega-6s Usurped Omega-3s In US Diet". http://www.medicalnewstoday.com/medicalnews.php?newsid=51575.
     140. ^ Trebunová, A.; Vasko, L.; Svedová, M.; Kasteľ, R.; Tucková, M.; Mach, P. (July 2007). "The influence of omega-3 polyunsaturated fatty acids feeding on composition of fatty acids in fatty tissues and eggs of laying hens". Deutsche Tierärztliche Wochenschrift 114 (7): 275–279. PMID 17724936.
     141. ^ Cherian, G. Effect of feeding full fat flax and canola seeds to laying hens on the fatty acids composition of eggs, embryos, and newly hatched chicks. http://www.fao.org/agris/search/display.do?f=./1991/v1717/US9138554.xml;US9138554
     142. ^ "Washington Post's Egg Taste Test Says Homegrown And Factory Eggs Taste The Same [UPDATED, POLL]". Huffingtonpost.com. http://www.huffingtonpost.com/2010/06/03/egg-taste-test-says-no-di_n_599286.html. Retrieved 2011-01-03.
     143. ^ http://www.nature.com/nature/journal/v187/n4736/abs/187511b0.html
     144. ^ Duckett, S. K., D. G. Wagner, et al. (1993). "Effects of time on feed on beef nutrient composition." J Anim Sci 71(8): 2079-88.
     145. ^ "Specially Labeled Lamb". http://www.sheep101.info/labeledlamb.html.
     146. ^ Azcona, J.O., Schang, M.J., Garcia, P.T., Gallinger, C., R. Ayerza (h), and Coates, W. (2008). "Omega-3 enriched broiler meat: The influence of dietary alpha-linolenic omega-3 fatty acid sources on growth, performance and meat fatty acid composition". Canadian Journal of Animal Science, Ottawa, Ontario, Canada, 88:257-269.
     147. ^ "Gourment Game - Amazing Nutrition Facts". http://www.macromeats-gourmetgame.com.au/Nutrition/AmazingNutritionFacts.aspx.
     148. ^ "Natural Health Product Monograph - Seal Oil [Health Canada, 2009]". Hc-sc.gc.ca. http://www.hc-sc.gc.ca/dhp-mps/prodnatur/applications/licen-prod/monograph/mono_seal_oil_huile_phoque-eng.php. Retrieved 2011-01-03.
     149. ^ European Parliament (9 November 2009). "MEPs adopt strict conditions for the placing on the market of seal products in the European Union". Hearings. European Parliament. http://www.europarl.europa.eu/sides/getDoc.do?pubRef=-//EP//TEXT+IM-PRESS+20090504IPR54952+0+DOC+XML+V0//EN. Retrieved 12 March 2010.
     150. ^ Journal of Dairy Science, 2006. 89:1956–1969. “The Linear Relationship between the Proportion of Fresh Grass in the Cow Diet, Milk Fatty Acid Composition, and Butter Properties”

 

Kiemelt ajánlatunk
2011 NetPharma Kft. Minden jog fenntartva!